CoChat

Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma

Open access

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Objective: To systematically review studies reporting survival data following neoadjuvant chemoradiation and orthotopic liver transplantation (NCR-OLT) for unresectable perihilar cholangiocarcinoma (p CC). Background: Despite survival improvements for other cancers, the prognosis of p CC remains dismal. Since publication of the Mayo protocol in 2000, increasing numbers of series globally are reporting outcomes after NCR-OLT. Methods: MEDLINE, EMBASE, Scopus, and Web of Science databases were searched from January 2000 to February 2019. A meta-analysis of proportions was conducted, pooling 1, 3-, and 5-year overall survival and recurrence rates following NCR-OLT across centers. Per protocol and intention to treat data were interrogated. Meta-regression was used to evaluate PSC as a confounder affecting survival. Results: Twenty studies comprising 428 patients were eligible for analysis. No RCTs were retrieved; the majority of studies were noncomparative cohort studies. The pooled 1, 3-, and 5-year overall survival rates following OLT without neoadjuvant therapy were 71.2% (95% CI 62.2%–79.4%), 48.0% (95% CI 35.0%–60.9%), and 31.6% (95% CI 23.1%–40.7%). These improved to 82.8% (95% CI 73.0%–90.8%), 65.5% (95% CI 48.7%–80.5%), and 65.1% (95% CI 55.1%–74.5%) if neoadjuvant chemoradiation was completed. Pooled recurrence after 3 years was 24.1% (95% CI 17.9%–30.9%) with neoadjuvant chemoradiation, 51.7% (95% CI 33.8%–69.4%) without. Conclusions: In unresectable p CC, NCR-OLT confers long-term survival in highly selected patients able to complete neoadjuvant chemoradiation followed by transplantation. PSC patients appear to have the most favorable outcomes. A high recurrence rate is of concern when considering extending national graft selection policy to p CC.

Overview

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000003801

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Cited by

See all 141

Metadata

Authors
Cambridge, W. A., Fairfield, C., Powell, J. J., Harrison, E. M., Søreide, K., Wigmore, S. J., & Guest, R. V.
Affiliations
  • University of Edinburgh (GB)
  • Stavanger University Hospital (NO)
Corresponding author
  • Cambridge, William A.
  • Fairfield, Cameron
  • Powell, James J.
  • Harrison, Ewen M.
  • Wigmore, Stephen J.
  • Guest, Rachel V.
Venue
Annals of Surgery
Published
2020-02-24
Volume
273
Issue
2
Pages
240-250
ISSN
  • 0003-4932 (ISSN-L)
  • 1528-1140
OpenAlex
W3008946274
Cited by
141
References
52
Citations by year
2026: 21 · 2025: 18 · 2024: 22 · 2023: 29 · 2022: 22 · 2021: 17 · 2020: 11
FWCI
4.64
Type
journal article
Language
en
Open access
Locations
  • Annals of Surgery (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Funders
  • Academy of Medical Sciences (SGL018\1051)
  • Medical Research Council (MR/K017047/1)
Topics
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
Keywords
hilar cholangiocarcinoma, unresectable cholangiocarcinoma, orthotopic liver transplantation, neoadjuvant chemoradiotherapy, overall survival, tumor recurrence, primary sclerosing cholangitis, graft selection, long-term outcomes
MeSH terms
Bile Duct Neoplasms, Humans, Regression Analysis, Survival Rate, Liver Transplantation, Klatskin Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma. https://app.cochat.ai/papers/10.1097/sla.0000000000003801
The paper
Cambridge, W. A., Fairfield, C., Powell, J. J., Harrison, E. M., Søreide, K., Wigmore, S. J., & Guest, R. V. (2021). Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma. Annals of Surgery. https://doi.org/10.1097/sla.0000000000003801

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.